Showing results (161-170 of 745) with videos related to

Sort By:
Pageof 75
Neurologia|January 26, 2024
Fatigue in patients with acquired brain damageA Juárez-Belaúnde, E Orcajo, S Lejarreta, et al.
Neurologia|March 29, 2024
Covid-19 in Parkinson's Disease treated by drugs or brain stimulationM Salari, M Etemadifar, A Zali, et al.
Neurologia|November 23, 2023
Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of casesM Carmona-Abellan, R Del Pino, A Murueta-Goyena, et al.
Neurologia|October 6, 2023
Safety and efficacy of the Low-Profile Visualized Intraluminal Support stent in treating intracranial atherosclerotic stenosisJ-W Wang, X-Y Li, C-H Li, et al.
Neurologia|July 13, 2023
Variations of the grid and place cells in the entorhinal cortex and dentate gyrus of 6 individuals aged 56 to 87 yearsI González-Marrero, J A Hernandez-Garcia, E Gonzalez-Davila, et al.
Neurologia|July 7, 2023
Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situationsD Santos García, J Pagonabarraga Mora, F Escamilla Sevilla, et al.
Neurologia|September 2, 2023
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's diseaseA R Bentivoglio, M R Lo Monaco, R Liperoti, et al.
Neurologia|September 2, 2023
Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumabE M Alba Suárez, A Tallón Barranco, I Puertas Muñoz, et al.
Neurologia|June 1, 2023
Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™D Santos García, N López Ariztegui, E Cubo, et al.
Neurologia|June 1, 2023
Determinants and impact of alexithymia on quality of life in Parkinson's diseaseA Alvarado-Bolaños, A Cervantes-Arriaga, L Zuazua-Vidal, et al.
Pageof 75